30006000330066003300660036007200
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)

30006000330066003300660036007200
5T/box(Ⅰ-01)10T/box(Ⅰ-02)5T/box(Ⅱ-01)10T/box(Ⅱ-02)5T/box(Ⅲ-01)10T/box(Ⅲ-02)5T/box(Ⅳ-01)10T/box (IV-02)
Lymphoma
The 2016 edition of the WHO proposed the subtype “ALK-negative ALCL (mesenchymal large cell lymphoma)”, and TP63 rearrangement accounts for about 8% of ALK break-negative cases, with a poor prognosis and a 5-year survival rate of about 17%.TP63 is an oncogene, and gene rearrangements of TP63 are frequently detected in T-cell lymphomas. TP63 is an oncogene, and TP63 rearrangements are frequently detected in T-cell lymphomas, most of which are fusions with TBX1R1, and translocations between TP63 and TBL1 have also been found in follicular lymphomas.